BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

PLoS By Category | Recent PLoS Articles
Immunology - Molecular Biology - Neurological Disorders - Neuroscience - Physiology

Interferon-? Activates Nuclear Factor-? B in Oligodendrocytes through a Process Mediated by the Unfolded Protein Response
Published: Friday, May 04, 2012
Author: Yifeng Lin et al.

by Yifeng Lin, Stephanie Jamison, Wensheng Lin

Our previous studies have demonstrated that the effects of the immune cytokine interferon-? (IFN-?) in immune-mediated demyelinating diseases are mediated, at least in part, by the unfolded protein response (UPR) in oligodendrocytes. Data indicate that some biological effects of IFN-? are elicited through activation of the transcription factor nuclear factor-?B (NF-?B). Interestingly, it has been shown that activation of the pancreatic endoplasmic reticulum kinase (PERK) branch of the UPR triggers NF-?B activation. In this study, we showed that IFN-?-induced NF-?B activation was associated with activation of PERK signaling in the oligodendroglial cell line Oli-neu. We further demonstrated that blockage of PERK signaling diminished IFN-?-induced NF-?B activation in Oli-neu cells. Importantly, we showed that NF-?B activation in oligodendrocytes correlated with activation of PERK signaling in transgenic mice that ectopically express IFN-? in the central nervous system (CNS), and that enhancing IFN-?-induced activation of PERK signaling further increased NF-?B activation in oligodendrocytes. Additionally, we showed that suppression of the NF-?B pathway rendered Oli-neu cells susceptible to the cytotoxicity of IFN-?, reactive oxygen species, and reactive nitrogen species. Our results indicate that the UPR is involved in IFN-?-induced NF-?B activation in oligodendrocytes and suggest that NF-?B activation by IFN-? represents one mechanism by which IFN-? exerts its effects on oligodendrocytes in immune-mediated demyelinating diseases.